首页> 美国卫生研究院文献>The Journal of Infectious Diseases >Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

【2h】

Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

机译：EB66细胞培养的甲型流感/印度尼西亚/ 5/2005（H5N1）AS03佐剂疫苗的免疫原性和安全性：1期随机试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

BackgroundCell-culture-derived (CC) influenza vaccine production methods could provide benefits over classical embryonated-egg technology, including a higher production capacity and the faster creation of a supply that meets demand.

机译：背景技术细胞培养衍生（CC）流感疫苗的生产方法可以提供优于传统胚胎蛋技术的好处，包括更高的生产能力和更快地满足需求的供应。

著录项

期刊名称 The Journal of Infectious Diseases
作者
Anne Schuind; Nathan Segall; Mamadou Drame; Bruce L. Innis;
展开▼
作者单位

展开▼
年(卷),期 -1(212),4
年度 -1
页码 531–541
总页数 11
原文格式 PDF
正文语种
中图分类免疫学;微生物学;病毒传染病;
关键词
influenza A(H5N1) pandemic influenza vaccine AS03 cell culture;

机译：甲型H5N1流感大流行性流感疫苗AS03细胞培养;

相似文献

外文文献
中文文献
专利

1. Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005 (H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial [J] . Schuind Anne, Segall Nathan, Drame Mamadou, The Journal of Infectious Diseases . 2015,第4期

机译：EB66细胞培养源性流感A /印度尼西亚/ 5/2005（H5N1）AS03佐剂疫苗的免疫原性和安全性：1期随机试验
2. Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase 1/2 trial in adults. [J] . Langley JM, Frenette L, Ferguson L, The Journal of Infectious Diseases . 2010,第11期

机译：候选AS03佐剂大流行H5N1流感疫苗的安全性和交叉反应性免疫原性：成人的随机对照1/2期临床试验。
3. Safety and Cross-Reactive Immunogenicity of Candidate AS03-Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults [J] . Joanne M. Langley, Louise Frenette, Linda Ferguson, Journal of Infectious Diseases . 2010,第11期

机译：候选AS03佐剂大流行H5N1流感疫苗的安全性和交叉反应免疫原性：成人的随机对照1/2期试验。
4. A double-blind, randomized phase II trial of thesafety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adults [C] . Shelly A. McNeil, Scott A. Halperin, Joanne M. Langley, Lancefield International Symposium on Streptococci and Streptococcal Diseases . 2006

机译：一种双盲，随机期II试验，对健康成人的26岁的26岁群体的疫苗疫苗
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Safety and Immunogenicity of a Plant-Produced Recombinant Hemagglutinin-Based Influenza Vaccine (HAI-05) Derived from A/Indonesia/05/2005 (H5N1) Influenza Virus: A Phase 1 Randomized Double-Blind Placebo-Controlled Dose-Escalation Study in Healthy Adults [O] . Jessica A. Chichester, R. Mark Jones, Brian J. Green, 2012

机译：源自A / Indonesia / 05/2005（H5N1）流感病毒的植物生产的基于血凝素的重组流感疫苗（HAI-05）的安全性和免疫原性：1期随机双盲安慰剂控制剂量递增的阶段健康成年人的学习
7. Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial [O] . Anne Schuind, Nathan Segall, Mamadou Drame, 2015

机译：EB66细胞培养型流感A / INDONESIA / 5/2005（H5N1）AS03辅助疫苗的免疫原性和安全性：1期随机试验

Immunogenicity and Safety of an EB66 Cell-Culture-Derived Influenza A/Indonesia/5/2005(H5N1) AS03-Adjuvanted Vaccine: A Phase 1 Randomized Trial

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅